Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Change in Working Capital
-$366.00K
Quarterly · Period ending: · USD
LCTX Change in Working Capital
Latest reported-$366.00Kperiod ending
Latest reported-$366.00Kperiod ending
LCTX Quarterly Change in Working Capital ($4.30M → -$366.00K)
Quarterly change in working capital
High-resolution chart · PNG
LCTX change in working capital history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Change in Working Capital (USD) |
|---|---|
| -366,000 | |
| -2,118,000 | |
| 83,000 | |
| -1,573,000 | |
| -2,352,000 | |
| -268,000 | |
| -3,017,000 | |
| -3,712,000 | |
| -1,108,000 | |
| -929,000 | |
| -1,227,000 | |
| -134,000 | |
| -3,021,000 | |
| -6,336,000 | |
| -2,831,000 | |
| -928,000 | |
| -4,661,000 | |
| 27,124,000 | |
| 21,286,000 | |
| 656,000 | |
| 502,000 | |
| -1,334,000 | |
| -693,000 | |
| 972,000 | |
| 252,000 | |
| 597,000 | |
| -671,000 | |
| -1,073,000 | |
| -1,056,000 | |
| 844,000 | |
| 1,271,000 | |
| 720,000 | |
| -484,000 | |
| -869,000 | |
| 1,533,000 | |
| -632,000 | |
| 105,000 | |
| 1,472,000 | |
| 709,000 | |
| -2,223,000 | |
| -501,000 | |
| 1,274,000 | |
| 1,480,000 | |
| 868,000 | |
| 1,326,034 | |
| -369,034 | |
| 1,108,107 | |
| 814,440 | |
| -1,032,232 | |
| -1,717,365 | |
| 1,419,829 | |
| 2,040,132 | |
| -673,187 | |
| -60,972 | |
| 867,609 | |
| -363,194 | |
| 932,225 | |
| -968,627 | |
| 720,446 | |
| -845,353 | |
| 958,044 | |
| -807,015 | |
| -412,744 | |
| -87,096 | |
| 126,576 | |
| -74,499 | |
| 188,259 | |
| -749,416 | |
| 275,721 | |
| -20,664 | |
| 1,022,721 | |
| 357,607 | |
| -30,642 | |
| 92,740 | |
| 120,716 | |
| -6,344 | |
| -81,008 | |
| 73,595 | |
| 51,176 | |
| 41,815 | |
| 507,852 | |
| -331,408 | |
| 802,946 | |
| -315,228 | |
| -42,837 | |
| 40,692 | |
| 296,055 | |
| 255,051 | |
| 1,359 | |
| -198,922 | |
| -154,802 | |
| -78,195 | |
| 362,195 | |
| -3,196 | |
| 60,696 | |
| -119,276 | |
| 260,829 | |
| -127,913 | |
| 106,671 | |
| -164,140 |